News in the Life Sciences Industry

- Combining Intravacc's OMV-delivery platform with COVID-19 Spike proteins

SAN JOSE, Calif., July 29, 2020 /PRNewswire/ -- Eargo, a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the closing of a $71 million equity financing, led by new co-investors Gilde Healthcare and Longitude Capital, with existing... Read more ››

NEW YORK, July 29, 2020 /PRNewswire/ -- College mental health provider Mantra Health today announced the addition... Read more ››

NEWARK, Calif., July 29, 2020 /PRNewswire/ -- Socket Mobile, Inc. (NASDAQ: SCKT), a leading innovator of data capture and delivery solutions for enhanced productivity, today announced the availability of the DuraScan(®) D755 - a medical-grade, universal scanner designed and built for healthcare... Read more ››

NEW YORK, July 29, 2020 /PRNewswire/ -- The Republic of Korea's Daejeon City Government has commissioned DriWay Technologies to install its dehydration devices in the city's bomb shelters, to reduce the invasive moisture within the structures. This partnership begins with a three-month pilot... Read more ››

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 29, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended June 30, 2020.

SAN JOSE, Calif., July 29, 2020 /PRNewswire/ -- A new pre-print runs a head-to-head comparison between Loop Genomics, PacBio and Oxford Nanopore's accuracy in long read microbiome sequencing.

Project delivers a combined solution for end-to-end visibility in EU, Korea and U.S. markets

- UCB to provide to Roche and Genentech exclusive, world-wide license to UCB's UCB0107, an innovative anti-Tau antibody treatment

SYDNEY, July 28, 2020 /PRNewswire/ -- Atomo has announced that it has signed a binding agreement with US-based diagnostics specialist Access Bio Inc. (KOSDAQ: 950130) (Access Bio) that will see Atomo supply its unique, integrated rapid diagnostic test (RDT) devices to Access... Read more ››

SAN FRANCISCO, July 28, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2020 on Thursday, August 6, 2020, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference... Read more ››

DUBLIN, July 28, 2020 /PRNewswire/ -- The Read more ››

SHANGHAI and NEWYORK, July 28, 2020 /PRNewswire/ -- Viva Biotech Holdings (1873.HK) and Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo crystal structures of high-value targets.

The company selected the platform to help streamline its drug discovery data management process